Literature DB >> 17037573

Equine viral arteritis.

N James MacLachlan1, Udeni B Balasuriya.   

Abstract

EVA is an important if uncommon disease of horses. Potential economic losses attributable to EVA include direct losses from abortion, pneumonia in neonates, and febrile disease in performance horses. Indirect losses are those associated with national and international trade/animal movement regulations, particularly those pertaining to persistently infected carrier stallions and their semen. However, EAV infection and EVA are readily prevented through serological and virological screening of horses, coupled with sound management practices that include appropriate quarantine and strategic vaccination.

Entities:  

Mesh:

Year:  2006        PMID: 17037573      PMCID: PMC7123899          DOI: 10.1007/978-0-387-33012-9_77

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

Review 1.  The molecular biology of arteriviruses.

Authors:  E J Snijder; J J Meulenberg
Journal:  J Gen Virol       Date:  1998-05       Impact factor: 3.891

Review 2.  Togaviridae.

Authors:  E G Westaway; M A Brinton; M C Horzinek; A Igarashi; L Kääriäinen; D K Lvov; J S Porterfield; P K Russell; D W Trent
Journal:  Intervirology       Date:  1985       Impact factor: 1.763

3.  Phylogenetic characterization of a highly attenuated strain of equine arteritis virus from the semen of a persistently infected standardbred stallion.

Authors:  J F Patton; U B Balasuriya; J F Hedges; T M Schweidler; P J Hullinger; N J MacLachlan
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

4.  Genetic divergence with emergence of novel phenotypic variants of equine arteritis virus during persistent infection of stallions.

Authors:  J F Hedges; U B Balasuriya; P J Timoney; W H McCollum; N J MacLachlan
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 5.  The immune response to equine arteritis virus: potential lessons for other arteriviruses.

Authors:  Udeni B R Balasuriya; N James MacLachlan
Journal:  Vet Immunol Immunopathol       Date:  2004-12-08       Impact factor: 2.046

6.  Seroprevalence of antibodies against equine arteritis virus in horses residing in the United States and imported horses.

Authors:  P J Hullinger; I A Gardner; S K Hietala; G L Ferraro; N J MacLachlan
Journal:  J Am Vet Med Assoc       Date:  2001-10-01       Impact factor: 1.936

7.  Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone.

Authors:  Udeni B R Balasuriya; Jessika C Dobbe; Hans W Heidner; Victoria L Smalley; Andrea Navarrette; Eric J Snijder; N James MacLachlan
Journal:  Virology       Date:  2004-04-10       Impact factor: 3.616

8.  Genetic characterization of equine arteritis virus during persistent infection of stallions.

Authors:  Udeni B R Balasuriya; Jodi F Hedges; Victoria L Smalley; Andrea Navarrette; William H McCollum; Peter J Timoney; Eric J Snijder; N James MacLachlan
Journal:  J Gen Virol       Date:  2004-02       Impact factor: 3.891

9.  Phylogenetic analysis of open reading frame 5 of field isolates of equine arteritis virus and identification of conserved and nonconserved regions in the GL envelope glycoprotein.

Authors:  U B Balasuriya; P J Timoney; W H McCollum; N J MacLachlan
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

Review 10.  Equine viral arteritis.

Authors:  P J Timoney; W H McCollum
Journal:  Vet Clin North Am Equine Pract       Date:  1993-08       Impact factor: 1.792

View more
  6 in total

1.  Development and characterization of an infectious cDNA clone of the modified live virus vaccine strain of equine arteritis virus.

Authors:  Jianqiang Zhang; Yun Young Go; Chengjin M Huang; Barry J Meade; Zhengchun Lu; Eric J Snijder; Peter J Timoney; Udeni B R Balasuriya
Journal:  Clin Vaccine Immunol       Date:  2012-06-27

2.  Expression of the Heterotrimeric GP2/GP3/GP4 Spike of an Arterivirus in Mammalian Cells.

Authors:  Anna Karolina Matczuk; Minze Zhang; Michael Veit; Maciej Ugorski
Journal:  Viruses       Date:  2022-04-01       Impact factor: 5.818

3.  Folding and oligomerization of the gp2b/gp3/gp4 spike proteins of equine arteritis virus in vitro.

Authors:  Aleksander Kabatek; Michael Veit
Journal:  Viruses       Date:  2012-03-22       Impact factor: 5.048

Review 4.  Hidden behind autophagy: the unconventional roles of ATG proteins.

Authors:  Jovanka Bestebroer; Philip V'kovski; Mario Mauthe; Fulvio Reggiori
Journal:  Traffic       Date:  2013-07-30       Impact factor: 6.215

Review 5.  Experiences with infectious cDNA clones of equine arteritis virus: lessons learned and insights gained.

Authors:  Udeni B R Balasuriya; Jianqiang Zhang; Yun Young Go; N James MacLachlan
Journal:  Virology       Date:  2014-06-07       Impact factor: 3.616

Review 6.  Equine arteritis virus.

Authors:  Udeni B R Balasuriya; Yun Young Go; N James MacLachlan
Journal:  Vet Microbiol       Date:  2013-07-03       Impact factor: 3.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.